Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
August 16, 2013
Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies
P Jacqmin, J R Wade, B Weatherley, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 20, 2006
Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model
P Jacqmin, E Snoeck, E A van Schaick, et al.
Annales De La Societe Belge De Medecine Tropicale
|
September 1, 1995
Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum
G Pierard-Franchimont, P De Doncker, V Van de Velde, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 10, 1998
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine
E Snoeck, K Ver Donck, P Jacqmin, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 1998
Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children
L de Repentigny, J Ratelle, J M Leclerc, et al.
Renal Failure
|
January 1, 1990
Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease
S Ibrahim, M P Derde, L Kaufman, et al.
Platelets
|
November 4, 2010
Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIa
S G Panzer-Knodle, P Jacqmin, J D Page, et al.
Clinical Pharmacology and Therapeutics
|
October 6, 2016
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
E Monnet, G Lapeyre, E van Poelgeest, et al.
Archives of Dermatology
|
January 1, 1996
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole
P De Doncker, J Decroix, G E Piérard, et al.
Clinical Pharmacology and Therapeutics
|
May 14, 2010
A comprehensive hepatitis C viral kinetic model explaining cure
E Snoeck, P Chanu, M Lavielle, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
CPT: Pharmacometrics & Systems Pharmacology
|
August 16, 2013
Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies
P Jacqmin, J R Wade, B Weatherley, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 20, 2006
Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model
P Jacqmin, E Snoeck, E A van Schaick, et al.
Annales De La Societe Belge De Medecine Tropicale
|
September 1, 1995
Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum
G Pierard-Franchimont, P De Doncker, V Van de Velde, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 10, 1998
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine
E Snoeck, K Ver Donck, P Jacqmin, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 1998
Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children
L de Repentigny, J Ratelle, J M Leclerc, et al.
Renal Failure
|
January 1, 1990
Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease
S Ibrahim, M P Derde, L Kaufman, et al.
Platelets
|
November 4, 2010
Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIa
S G Panzer-Knodle, P Jacqmin, J D Page, et al.
Clinical Pharmacology and Therapeutics
|
October 6, 2016
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
E Monnet, G Lapeyre, E van Poelgeest, et al.
Archives of Dermatology
|
January 1, 1996
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole
P De Doncker, J Decroix, G E Piérard, et al.
Clinical Pharmacology and Therapeutics
|
May 14, 2010
A comprehensive hepatitis C viral kinetic model explaining cure
E Snoeck, P Chanu, M Lavielle, et al.
Page
of 4